Building on these results, we found for the first time a link between induced STAT3 signaling and hepatocyte-specific SMAD7 deficiency in DEN mice and human HCC, thus unraveling a new tumor-suppressive mechanism for SMAD7 in HCC. This evidence concerns the gene STAT3 and hepatocellular carcinoma.